Few prospective, population-based, long-term follow-up studies exist on peo
ple with epilepsy. Still fewer reports cover social outcome. Overall mortal
ity is two to three times higher than expected. The contribution of epileps
y is variable. Importantly, the type of epilepsy syndrome and gender must b
e considered in the estimation of mortality rates in epilepsy. Sudden unexp
ected death and its mechanisms also need. further consideration. mortality
is two to three times higher than expected. The contribution of Approximate
ly. two thirds of surviving patients will be in terminal remission twenty y
ears after onset of epilepsy and half of them are seizure-free without medi
cation. The best independent predictors of remission are absence of organic
brain damage, low intensity seizure propensity and good early effect of dr
ug therapy. The long-term outcome is often predictable by observation of th
e early outcome of seizures. One third of children with epilepsy are mental
ly retarded. Poor social outcome is related to associated neurological disa
bilities, drug resistant seizures and polytherapy. However, even patients w
ith uncomplicated epilepsy, idiopathic etiology and terminal remission with
out medication do less favourably than their matched controls in basic and
vocational education, and reproductive activity. The employability of this
subgroup, however, does not differ significantly from that of controls, com
pared with approximately 60% of all people with epilepsy. Further research
is needed particularly to enable a better determination of predictors of lo
ng-term outcome, recurrence of seizures after drug withdrawal and the role
of drug therapy in long-term prognosis.